Pentraxin 3 (PTX3) expression in allergic asthmatic airways: Role in airway smooth muscle migration and chemokine production

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Zhang, Jingbo ^a,c   Shan, Lianyu ^a   Koussih, Latifa ^a   Redhu, Naresh Singh ^a   Halayko, Andrew J ^a   Chakir, Jamila ^b   Gounni, Abdelilah S ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHEMOKINE; CYTOKINE; EOTAXIN; FIBROBLAST GROWTH FACTOR 2; FLUTICASONE; GAMMA INTERFERON; HISTONE H3; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 9; MESSENGER RNA; PENTRAXIN 3; THYMIDINE; TUMOR NECROSIS FACTOR;

ADULT; ALLERGIC ASTHMA; ARTICLE; BRONCHUS; BRONCHUS BIOPSY; CELL COUNT; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; TH1 CELL; TH17 CELL; TH2 CELL; UPREGULATION;

ADOLESCENT; ADULT; ASTHMA; BIOPSY; BRONCHI; C-REACTIVE PROTEIN; CHEMOKINE CCL11; CHEMOKINES; CHEMOTAXIS; CYTOKINES; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; SERUM AMYLOID P-COMPONENT; TH1 CELLS; TH2 CELLS; YOUNG ADULT;

EID: 84859977255     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034965     Document Type: Article

References (65)

1. Dekkers BG, Maarsingh H, Meurs H, Gosens R, (2009) Airway structural components drive airway smooth muscle remodeling in asthma. Proc Am Thorac Soc 6: 683-692.
2. Tliba O, Panettieri RA Jr, (2009) Noncontractile functions of airway smooth muscle cells in asthma. Annu Rev Physiol 71: 509-535.
3. Halayko AJ, Amrani Y, (2003) Mechanisms of inflammation-mediated airway smooth muscle plasticity and airways remodeling in asthma. Respir Physiol Neurobiol 137: 209-222.
4. Panettieri RA Jr, (2003) Airway smooth muscle: immunomodulatory cells that modulate airway remodeling? Respir Physiol Neurobiol 137: 277-293.
5. Gounni AS, (2006) The high-affinity IgE receptor (FcepsilonRI): a critical regulator of airway smooth muscle cells? Am J Physiol Lung Cell Mol Physiol 291: L312-321.
6. Gounni AS, Wellemans V, Yang J, Bellesort F, Kassiri K, et al. (2005) Human airway smooth muscle cells express the high affinity receptor for IgE (Fc epsilon RI): a critical role of Fc epsilon RI in human airway smooth muscle cell function. J Immunol 175: 2613-2621.
7. Redhu NS, Saleh A, Shan L, Gerthoffer WT, Kung SK, et al. (2009) Proinflammatory and Th2 cytokines regulate the high affinity IgE receptor (FcepsilonRI) and IgE-dependant activation of human airway smooth muscle cells. PLoS One 4: e6153.
8. Roth M, Tamm M, (2010) The effects of omalizumab on IgE-induced cytokine synthesis by asthmatic airway smooth muscle cells. Ann Allergy Asthma Immunol 104: 152-160.
9. Hakonarson H, Grunstein MM, (1998) Autologously up-regulated Fc receptor expression and action in airway smooth muscle mediates its altered responsiveness in the atopic asthmatic sensitized state. Proc Natl Acad Sci U S A 95: 5257-5262.
10. Chambers LS, Black JL, Ge Q, Carlin SM, Au WW, et al. (2003) PAR-2 activation, PGE2, and COX-2 in human asthmatic and nonasthmatic airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 285: L619-627.
11. Chambers LS, Black JL, Poronnik P, Johnson PR, (2001) Functional effects of protease-activated receptor-2 stimulation on human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 281: L1369-1378.
12. Roth M, Tamm M, (2010) Airway smooth muscle cells directly respond to inhaled environmental factors. Swiss Med Wkly.
13. Manfredi AA, Rovere-Querini P, Bottazzi B, Garlanda C, Mantovani A, (2008) Pentraxins, humoral innate immunity and tissue injury. Curr Opin Immunol 20: 538-544.
14. Ortega-Hernandez OD, Bassi N, Shoenfeld Y, Anaya JM, (2008) The Long Pentraxin 3 and Its Role in Autoimmunity. Semin Arthritis Rheum.
15. Latini R, Maggioni AP, Peri G, Gonzini L, Lucci D, et al. (2004) Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 110: 2349-2354.
16. Fazzini F, Peri G, Doni A, Dell'Antonio G, Dal Cin E, et al. (2001) PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum 44: 2841-2850.
17. Luchetti MM, Piccinini G, Mantovani A, Peri G, Matteucci C, et al. (2000) Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA). Clin Exp Immunol 119: 196-202.
18. Tong M, Carrero JJ, Qureshi AR, Anderstam B, Heimburger O, et al. (2007) Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. Clin J Am Soc Nephrol 2: 889-897.
19. Azzurri A, Sow OY, Amedei A, Bah B, Diallo S, et al. (2005) IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect 7: 1-8.
20. Mauri T, Coppadoro A, Bellani G, Bombino M, Patroniti N, et al. (2008) Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity. Crit Care Med 36: 2302-2308.
21. Doni A, Peri G, Chieppa M, Allavena P, Pasqualini F, et al. (2003) Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells. Eur J Immunol 33: 2886-2893.
22. Shelton RC, Liang S, Liang P, Chakrabarti A, Manier DH, et al. (2004) Differential expression of pentraxin 3 in fibroblasts from patients with major depression. Neuropsychopharmacology 29: 126-132.
23. Jaillon S, Peri G, Delneste Y, Fremaux I, Doni A, et al. (2007) The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 204: 793-804.
24. Norata GD, Marchesi P, Pirillo A, Uboldi P, Chiesa G, et al. (2008) Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol 28: 925-931.
25. Doni A, Mantovani G, Porta C, Tuckermann J, Reichardt HM, et al. (2008) Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and nonhematopoietic cells. J Biol Chem 283: 29983-29992.
26. Han B, Mura M, Andrade CF, Okutani D, Lodyga M, et al. (2005) TNFalpha-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK. J Immunol 175: 8303-8311.
27. Klouche M, Peri G, Knabbe C, Eckstein HH, Schmid FX, et al. (2004) Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells. Atherosclerosis 175: 221-228.
28. Bozza S, Bistoni F, Gaziano R, Pitzurra L, Zelante T, et al. (2006) Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. Blood 108: 3387-3396.
29. Garlanda C, Hirsch E, Bozza S, Salustri A, De Acetis M, et al. (2002) Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 420: 182-186.
30. Gaziano R, Bozza S, Bellocchio S, Perruccio K, Montagnoli C, et al. (2004) Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals. Antimicrob Agents Chemother 48: 4414-4421.
31. Salustri A, Garlanda C, Hirsch E, De Acetis M, Maccagno A, et al. (2004) PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization. Development 131: 1577-1586.
32. Camozzi M, Rusnati M, Bugatti A, Bottazzi B, Mantovani A, et al. (2006) Identification of an antiangiogenic FGF2-binding site in the N terminus of the soluble pattern recognition receptor PTX3. J Biol Chem 281: 22605-22613.
33. Deban L, Russo RC, Sironi M, Moalli F, Scanziani M, et al. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol 11: 328-334.
34. Fregonese L, Swan FJ, van Schadewijk A, Dolhnikoff M, Santos MA, et al. (2005) Expression of the anaphylatoxin receptors C3aR and C5aR is increased in fatal asthma. J Allergy Clin Immunol 115: 1148-1154.
35. Renauld JC, (2001) New insights into the role of cytokines in asthma. J Clin Pathol 54: 577-589.
36. Amrani Y, (2007) TNF-alpha and calcium signaling in airway smooth muscle cells: a never-ending story with promising therapeutic relevance. Am J Respir Cell Mol Biol 36: 387-388.
37. Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, et al. (2006) Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 354: 697-708.
38. Maina V, Cotena A, Doni A, Nebuloni M, Pasqualini F, et al. (2009) Coregulation in human leukocytes of the long pentraxin PTX3 and TSG-6. J Leukoc Biol 86: 123-132.
39. Camozzi M, Zacchigna S, Rusnati M, Coltrini D, Ramirez-Correa G, et al. (2005) Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo. Arterioscler Thromb Vasc Biol 25: 1837-1842.
40. Bosse Y, Rola-Pleszczynski M, (2008) FGF2 in asthmatic airway-smooth-muscle-cell hyperplasia. Trends Mol Med 14: 3-11.
41. Mauri T, Bellani G, Patroniti N, Coppadoro A, Peri G, et al. Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Intensive Care Med 36: 621-629.
42. Dias AA, Goodman AR, Dos Santos JL, Gomes RN, Altmeyer A, et al. (2001) TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis. J Leukoc Biol 69: 928-936.
43. Breviario F, d'Aniello EM, Golay J, Peri G, Bottazzi B, et al. (1992) Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem 267: 22190-22197.
44. Koppelman GH, Stine OC, Xu J, Howard TD, Zheng SL, et al. (2002) Genome-wide search for atopy susceptibility genes in Dutch families with asthma. J Allergy Clin Immunol 109: 498-506.
45. Van Pottelberge GR, Bracke KR, Pauwels NS, Vermassen FE, Joos GF, et al. (2011) COPD is associated with reduced pulmonary interstitial expression of Pentraxin-3. Eur Respir J.
46. Pizzichini MM, Kleveston T, Morato EF, Pinheiro JT, Steidle LJ, et al. (2009) Pentraxin 3 (PTX3): A New Marker To Study Airway Inflammation? Am J Respir Crit Care Med April 1: A2532.
47. Pauwels NS, Bracke KR, Maes T, Van Pottelberge GR, Garlanda C, et al. (2010) Cigarette smoke induces PTX3 expression in pulmonary veins of mice in an IL-1 dependent manner. Respir Res 11: 134.
48. Mantovani A, Garlanda C, Doni A, Bottazzi B, (2008) Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol 28: 1-13.
49. Scarchilli L, Camaioni A, Bottazzi B, Negri V, Doni A, et al. (2007) PTX3 interacts with inter-alpha-trypsin inhibitor: implications for hyaluronan organization and cumulus oophorus expansion. J Biol Chem 282: 30161-30170.
50. Varani S, Elvin JA, Yan C, DeMayo J, DeMayo FJ, et al. (2002) Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility. Mol Endocrinol 16: 1154-1167.
51. Humbles AA, Conroy DM, Marleau S, Rankin SM, Palframan RT, et al. (1997) Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med 186: 601-612.
52. Fulkerson PC, Fischetti CA, Rothenberg ME, (2006) Eosinophils and CCR3 regulate interleukin-13 transgene-induced pulmonary remodeling. Am J Pathol 169: 2117-2126.
53. Cheng SS, Lukacs NW, Kunkel SL, (2002) Eotaxin/CCL11 is a negative regulator of neutrophil recruitment in a murine model of endotoxemia. Exp Mol Pathol 73: 1-8.
54. Cheng SS, Lukacs NW, Kunkel SL, (2002) Eotaxin/CCL11 suppresses IL-8/CXCL8 secretion from human dermal microvascular endothelial cells. J Immunol 168: 2887-2894.
55. Fukakusa M, Bergeron C, Tulic MK, Fiset PO, Al Dewachi O, et al. (2005) Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa. J Allergy Clin Immunol 115: 280-286.
56. Salio M, Chimenti S, De Angelis N, Molla F, Maina V, et al. (2008) Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation 117: 1055-1064.
57. Redington AE, Roche WR, Madden J, Frew AJ, Djukanovic R, et al. (2001) Basic fibroblast growth factor in asthma: measurement in bronchoalveolar lavage fluid basally and following allergen challenge. J Allergy Clin Immunol 107: 384-387.
58. (1987) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 136: 225-244.
59. Shan L, Redhu NS, Saleh A, Halayko AJ, Chakir J, et al. (2010) Thymic stromal lymphopoietin receptor-mediated IL-6 and CC/CXC chemokines expression in human airway smooth muscle cells: role of MAPKs (ERK1/2, p38, and JNK) and STAT3 pathways. J Immunol 184: 7134-7143.
60. Naureckas ET, Ndukwu IM, Halayko AJ, Maxwell C, Hershenson MB, et al. (1999) Bronchoalveolar lavage fluid from asthmatic subjects is mitogenic for human airway smooth muscle. Am J Respir Crit Care Med 160: 2062-2066.
61. Redhu NS, Saleh A, Halayko AJ, Ali AS, Gounni AS, (2011) Essential role of NF-kappaB and AP-1 transcription factors in TNF-alpha-induced TSLP expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 300: L479-485.
62. Chakir J, Page N, Hamid Q, Laviolette M, Boulet LP, et al. (2001) Bronchial mucosa produced by tissue engineering: a new tool to study cellular interactions in asthma. J Allergy Clin Immunol 107: 36-40.
63. Semlali A, Jacques E, Plante S, Biardel S, Milot J, et al. (2008) TGF-beta suppresses EGF-induced MAPK signaling and proliferation in asthmatic epithelial cells. Am J Respir Cell Mol Biol 38: 202-208.
64. Goncharova EA, Lim P, Goncharov DA, Eszterhas A, Panettieri RA Jr, et al. (2006) Assays for in vitro monitoring of proliferation of human airway smooth muscle (ASM) and human pulmonary arterial vascular smooth muscle (VSM) cells. Nat Protoc 1: 2905-2908.
65. Goncharova EA, Goncharov DA, Krymskaya VP, (2006) Assays for in vitro monitoring of human airway smooth muscle (ASM) and human pulmonary arterial vascular smooth muscle (VSM) cell migration. Nat Protoc 1: 2933-2939.